ABSTRACT We have previously identified and purified a cell surface glycoprotein from retina and brain, called neural cell adhesion molecule or N-CAM, that appears to be involved in neural cell-cell adhesion, the fasciculation of neurites, and the formation of normal tissue patterns in the retina. The present studies reveal that artificial vesicles containing lipid and purified N-CAM bind to different cell types with a specificity similar to that of nerve cells. The same results were obtained with soluble N-CAM that had been briefly exposed to pH 3. In both cases the binding altered the rate of aggregation of neural cells and, like cell-cell adhesion, was inhibited by antibodies against N-CAM. The results support the proposal that N-CAM is a ligand in the formation of bonds between nerve cell membranes. Moreover, results of studies of vesicle-vesicle interactions and of N-CAM binding to cells coated with anti-(N-CAM) Fab' fragments were consistent with the idea that the N-CAM molecules on different cells may interact directly to form cell-cell bonds.
One ofthe major goals ofdevelopmental biology is to determine the molecular basis of cell-cell adhesion and to describe how this interaction contributes to the formation oftissues. Although an extensive literature exists on this subject (see ref. 1), a mechanism for cell-cell binding has not been established nor has any substance been directly demonstrated to be a part of such a bond.
In previous studies, we used an immunological approach (2) to identify and purify a cell adhesion molecule, called N-CAM, from nerve tissue (3) . Antibodies prepared against purified N-CAM specifically inhibit the aggregation of cells from nerve tissues (4) and therefore have been used to probe the physiological consequences of that aggregation. For example, anti-(N-CAM) has been used to demonstrate that N-CAM is involved in fasciculation of nerve fibers (5) as well as in the segregation ofcell bodies and neurites in cell aggregates (4) and retinal tissue (6) . Anti-(N-CAM) antibodies also influence the growth of fascicles toward a source of nerve growth factor (7) . Although these investigations have been useful in analyzing developmental events in which adhesion plays a major role, they do not indicate the precise mode ofaction of N-CAM, particularly whether it is involved in the formation of cell-cell bonds. So far, only indirect evidence has been obtained, such as the inhibition of aggregation of cells by anti-(N-CAM) Fab' fragments and a correlation of N-CAM concentration on the plasma membrane with the rate of cell aggregation (4, 8) . The present studies provide direct evidence to support the hypothesis that N-CAM may function as a ligand in cell-cell adhesion.
MATERIALS AND METHODS
Preparation ofN-CAM and Anti-(N-CAM). Purified N-CAM was obtained* from a Nonidet P-40 (British Drug House, Poole, England) extract of membranes from 14-day chicken brain by affinity chromatography using an anti-(N-CAM) monoclonal antibody coupled to Sepharose CL-2B (Pharmacia). N-CAM was eluted from the Sepharose with 50 mM diethylamine/1 mM EDTA/0.5% Nonidet P-40. The detergent was removed by using Biobeads SM-2 (Bio-Rad) (9) , and the protein was dialyzed against H20 and lyophilized. This material migrated in a single zone during electrophoresis in polyacrylamide gels containing sodium dodecyl sulfate. l"I-labeled N-CAM ('25I-N-CAM) was prepared by using the* chloramine-T procedure (10) . In most cases, the labeled N-CAM was subsequently dialyzed for 2 hr against 0.15 M acetate (pH 3) at 37TC and then against phosphate-buffered saline at pH 7.4 (PJ/NaCl) at 40C.
Rabbit anti-(N-CAM) was prepared by three successive injections of 400 ,Ag of N-CAM at monthly intervals in complete Freund's adjuvant, incomplete Freund's adjuvant, and saline, respectively. In some experiments, these antibodies were purified by affinity chromatography on N-CAM-derivatized Sepharose CL-2B. Mouse monoclonal antibodies that both bind N-CAM and inhibit nerve cell adhesion were obtained by hybridization and cloning techniques from spleens ofmice immunized with N-CAM.
Preparation of Cells. Retinal and brain cells representing most ofthe neurons ofthese tissues were obtained by treatment ofthe tissue from 10-day chicken embryos with 0.002% trypsin.
These cells display Ca2"-independent aggregation (11) and have N-CAM on their surface (4, 12) . Liver cells were dissociated from 11-day embryo tissue by treatment with collagenase, trypsin, and bovine serum (13) . Myoblasts were obtained from leg muscles of 11-day chicken embryos by treatment with 0.1% trypsin for 30 min at 37°C. After the myoblasts were allowed to recover for 4 hr at 37°C in a spinner culture (8), they were fractionated on a Ficoll density gradient to yield a population consisting of 70% myoblasts and 30% fibroblasts (14) . Fibroblasts were obtained from skin of 10-day chicken embryos by trypsinization (0.2% trypsin/0.2% EDTA, 30 min, 37°C). After the fibroblasts grew to confluence in monolayer cultures, they were harvested by trypsinization and then allowed to recover for 4 hr in a spinner culture.
Incorporation of N-CAM into Lipid Vesicles. Artificial membranes containing affinity-purified N-CAM were prepared by sonication of 30 mg of lipid in 1 ml of 0.5% Nonidet P-40/Pi/ NaCl buffer, addition of 1 mg N-CAM in 5 ml of the same buffer, removal of detergent with Biobeads SM-2 (9), and isolation of the vesicles by gel filtration on Sepharose CL-2B in Pi/NaCl tion. Lipids were either synthetic dioleylphosphatidylcholine (Sigma) or total brain lipid obtained by chloroform/methanol extraction of a crude membrane preparation (15) . To obtain fluorescent vesicles, 20 mM 6-carboxyfluorescein (Eastman) was included in the detergent solution. The presence of N-CAM on the exterior ofthe vesicles was indicated by the ability oftrypsin to degrade >90% of the lipid-associated protein. The size of these vesicles ranged from submicroscopic to about 0.2 tim in diameter (see Fig. 2 ).
Binding Assays. Binding of soluble N-CAM to cells was measured by incubation of 107cells with 2 Ig of 125I-labeled N-CAM (2 X 105 cpm) for 15 min at 250C in 200 p1 of Earle's minimal essential medium (EME medium) containing 3.5 mg of bovine serum albumin. The cells were then washed by centrifugation through 3.5% bovine serum albumin in EME medium and assayed in a y-ray spectrometer. The attachment of lipid vesicles containing N-CAM to cells was monitored by fluorescence microscopy after incubation of 100 Al of a 20% vesicle suspension with 5 x 106 cells in 2 ml of EME medium on a gyrotory shaker at 70 rpm for 15 min at 370C. Aggregation ofthe vesicles themselves was observed after a similar incubation for 2 hr without cells.
The binding of N-CAM to itself was examined by incubation of 10 jig of 125I-N-CAM (106 cpm) with 80 ,ul of N-CAM-Sepharose for 3 hr at 370C in 500 /.l of PjNaCl buffer containing 10 mg of bovine serum albumin per ml. After extensive washing, the bound radioactivity was measured in a y-ray spectrometer.
Cell-to-cell binding was measured, by using either a monolayer assay in which a suspension of fluorescein-labeled cells were incubated with a cell monolayer (8) Values are mean ± SD of three or four experiments.
* Determined by immunofluorescence staining with anti-(N-CAM).
tBinding between the indicated cell type and 1 mm2 of retinal cell monolayer.
t Vesicles containing carboxyfluorescein were visualized by fluorescence microscopy (see Fig. 1 ). § Percentage decrease in particle number during a 30-min incubation at 37"C and rotation at 90 rpm. ¶ Affinity-purified anti-(N-CAM) was present at 20 gg/ml during binding.
IIThe myoblast data were provided by M. Grumet in our laboratory. ** Cells were treated with 0.1% trypsin for 20 min at 370C and washed.
specificity of soluble N-CAM binding to different cell types was similar to that of intact cells from neural retinas (Tables 1 and  2 ). Although the pH 3-treated soluble N-CAM did have detectable effects on the rate of retinal cell adhesion in the rotation-suspension assay, they were less dramatic and more complex than those obtained with N-CAM vesicles. With gyrotory agitation at 200 rpm, addition of N-CAM at 100 jig/ml caused a 40% inhibition of aggregation; at 90 rpm, however, the rate was enhanced by about 30%. As suggested for vesicles, the enhancement observed with less agitation may reflect cell agglutination caused by interactions among soluble N-CAM molecules.
Coating of Cells with Anti-(N-CAM) Fab' Inhibits the Binding of Cells, Vesicles, and Soluble N-CAM. The antibody inhibition studies described above were carried out with Fab' fragments present in solution throughout the binding assay. In a second protocol, designed to test the hypothesis that binding involves the interaction of one N-CAM molecule with another, cells were preincubated with Fab' fragments for 15 min at 4°C, washed thoroughly, and then assayed for their binding properties. When retinal cells were coated with affinity-purified or (Table 4) , that vesicles containing only synthetic lipid and purified N-CAM spontaneously formed large aggregates (Fig. 2) , and that N-CAM appears to exist in solution as a heterodisperse oligomer. The binding of N-CAM to N-CAM-Sepharose was inhibited by anti-(N-CAM) Fab' and was subject to competition by unlabeled N-CAM but not by serum albumin. No binding of N-CAM was observed with un-derivatized Sepharose or with serum albumin coupled to Sepharose (Table 4) . Similarly, the aggregation of N-CAM vesicles was completely blocked by the presence ofanti-(N-CAM) Fab' fragments (Fig. 2) ; trypsinized N-CAM vesicles or vesicles consisting only of lipid did not aggregate.
The aggregation of N-CAM molecules in solution (or onto cells) probably accounts for the absence of a saturation plateau in the binding of soluble N-CAM to retinal cells (Fig. 3) , the highest point shown representing more than 2 x 107 molecules bound per cell. Although this phenomenon could reflect nonspecific adsorption of N-CAM to the cell surface, the absence Anti-(N-CAM) 120 ± 15 +/-2,013 ± 164 * Monoclonal Fab' was used at 20 ,g/ml, and unbound Fab' was removed by washing. The same result was obtained with affinity-purified Fab'.
t Binding of untreated cells to a monolayer of Fab'-coated cells (see Table 1 ). Values are the mean ± SD of three experiments. t Visual estimation of bound fluorescent vesicles. § See Table 2 for details. Values are the mean ± SD of three experiments. (Table 2) suggests that the initial attachment of N-CAM to the cells was specific. other antibodies against the neural cell surface. This activity was destroyed by protease, heat, and ionic detergents and was stimulated by brief exposure to low pH or by incorporation of N-CAM into or onto a lipid bilayer. It is therefore dependent upon both molecular conformation and environment. Although a molecule involved in cell-cell adhesion would be expected to have a binding affinity for surface membranes, no unequivocal evidence exists that the adhesion and binding phenomena are related. Removal of N-CAM from its natural environment could create a binding activity that is not involved in cell adhesion. This interpretation could accountfor the failure of the N-CAM-cell binding curve (Fig. 3) to reach a saturation plateau. Nevertheless, Fab' fragments that were bound to cells (which express N-CAM in a "'native" state) blocked binding of both N-CAM vesicles and soluble N-CAM. Therefore, an adventitious binding of purified N-CAM would require the unlikely possibility that such an "altered" molecule has a specific affinity for a native site on cell surface N-CAM and, moreover, that this site is covered by the same monoclonal Fab' fragments that inhibit cell-cell adhesion.
The alternative proposal that the binding of N-CAM to cells is related to neural cell adhesion is based on the following strong circumstantial evidence. (i) Both the cell adhesion and N-CAM binding phenomena were inhibited by anti-(N-CAM). (ii) Neither type ofbinding required calcium, in contrast to at least two other adhesion mechanisms (11) (12) (13) soluble N-CAM to various cell types was identical except for nerve-hepatocyte adhesion, which appears to be unrelated to interactions involving N-CAM. (vi) To date, anti-(N-CAM) is the only specific antibody against a neural cell surface component that inhibits adhesion among the neural cells used in our studies; moreover, the adhesion-blocking activity of polyspecific antisera against these cells was lost upon specific removal or neutralization of anti-(N-CAM) antibody.
Unequivocal evidence that N-CAM is a ligand in cell adhesion can be obtained only by characterizing a cell-cell bond in molecular detail. Little is known about the molecular interactions involved in cell adhesion, but the rapid and specific aggregation of N-CAM vesicles raises the possibility that N-CAM molecules can bind directly to each other to form a mem-brane-membrane link. Aggregation was observed with vesicles made with either crude brain lipids or pure dioleylphosphatidylcholine and therefore is unlikely to involve an interaction of N-CAM with a nonglycoprotein component of cellular origin. The binding of N-CAM to N-CAM-Sepharose and the aggregated state of N-CAM in solution may represent the same phenomenon although, in these cases, one must also consider the possibility of nonspecific aggregation, particularly via hydrophobic interactions.
The suggestion that interactions between N-CAM molecules are important in cell-cell adhesion was supported by the observation that the binding, by a nerve cell, of N-CAM, N-CAM vesicles, or other cells expressing N-CAM was strongly inhibited by the prior coating of that cell with monovalent Fab' fragments prepared from monoclonal anti-(N-CAM). These results do not exclude the possibility that, in cell-cell binding, N-CAM may bind to another kind of molecule as well as to itself. It is striking, however, that adhesion between two cells that was inhibitable by anti-(N-CAM) only occurred if both cells had N-CAM on their surface.
Taken together, the present experiments provide evidence in support of the idea that N-CAM is an important part of the ligating apparatus for the specific calcium-independent adhesion that occurs among nerve cells and their fibers. Nevertheless, a precise description of the binding process, in which each molecular component is identified and the interactions are defined chemically, will require considerably more information, particularly the elucidation of the detailed molecular structure of N-CAM.
